Microfluidic Tech Corp.

What Microfluidic Tech Corp. does

Microfluidics Corporation designs and manufactures high-shear Microfluidizer® processors and homogenizers used to produce nanoemulsions, lipid nanoparticles, liposomes, and to perform cell disruption at micro- and nano-scale. The company was founded in 1984 and has been a wholly-owned subsidiary of IDEX Corporation (NYSE: IEX) since 2011, operating as part of the IDEX MPT Group alongside Fitzpatrick, Matcon, Quadro, and Quadro Liquids. Its core technology is a proprietary fixed-geometry Interaction Chamber™ — available in ceramic or diamond — that delivers consistent high shear under precisely controlled pressures, enabling linear scalability from 1 mL lab volumes to thousands of liters per hour at production scale.

The product line spans lab/benchtop units (LM10, LM20, M110P, LV1, M110Y, HC Series, TAMARA), pilot scale (M110EH, M815), and production scale (M700 Series, M7250, MP350 Microlyser™), with cGMP-accredited variants qualified for pharmaceutical and biopharmaceutical manufacturing. Revenue is generated primarily through capital equipment sales plus a recurring aftermarket stream covering proprietary Interaction Chambers, spare parts, and maintenance/service contracts; an in-house application lab supports proof-of-concept and process development work for customers. Customer segments are led by Pharmaceutical/Biopharmaceutical and Biotechnology/Life Sciences, with secondary exposure to cosmetics, nutraceuticals/food, energy/advanced materials, and cannabis. Named users include MIT, Abcam, University of Massachusetts Amherst, Vrije Universiteit Amsterdam, HDT Bio, the Infectious Disease Research Institute, and Cayman Chemical.

The company sells through a direct enterprise field-sales motion supplemented by technical inside sales and regional subsidiaries in Germany and China (operating as Quadro China), with headquarters in Newton, Massachusetts. Go-to-market is content-driven — technical blog, webinars, application notes, and presence at industry events such as INTERPHEX and AAPS PharmSci 360 — reflecting a high-touch, consultative sales cycle typical of specialized industrial equipment vendors.

Name

Microfluidic Tech Corp.

Legal name

Microfluidics Corporation

Website

https://microfluidics-mpt.com

Company type

Private

Founded year

1984

Operating status

Operating

Short description

Microfluidics Corporation designs and manufactures high-shear Microfluidizer® processors and homogenizers for nanoemulsions, cell disruption, and lipid nanoparticle production. Founded in 1984 and a subsidiary of IDEX Corporation since 2011, it serves pharmaceutical, biotechnology, and industrial manufacturers globally with cGMP-accredited equipment.

Ownership category

akta.pro rank

Product category

High-pressure homogenization equipment

NAICS

Analytical Laboratory Instrument Manufacturing (334516), Research and Development in Nanotechnology (541713)

SIC

Laboratory Analytical Instruments (3826)

akta.pro primary industry

Fill-Finish & Aseptic Drug Product Manufacturing (Biologics/ATMP) (HLAGAGAG)

akta.pro secondary industries

Crystallization, Particle Engineering & Micronization Services (HLAGAHAJ), Biosensors & Lab-on-Chip (BioMEMS) (HDAHALAK)

Keywords

• High shear homogenizers
• Microfluidizer processors
• Cell disruption equipment
• Nanoemulsion manufacturing
• Lipid nanoparticle production

Headquarters

HQ city

Newton

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. High Shear Fluid Processors: Sale of Microfluidizer® and Microlyser™ processors across lab, pilot, and production scales. Equipment ranges from benchtop units (LM10, LM20, M110P, LV1, M110Y, HC Series) to pilot scale (M110EH, M815) to production scale (M700 Series, MP350). Revenue is generated through direct capital equipment sales with varying pressure ratings and configurations.
2. Interaction Chambers and Spare Parts: Proprietary replacement Interaction Chambers and aftermarket spare parts for Microfluidizer® processors. The fixed-geometry design requires specific replacement components.
3. Application Lab Services: Engineers provide application testing and development services using Microfluidizer technology to help customers achieve nanotechnology solutions.
4. Equipment Maintenance and Support: Comprehensive aftermarket services including maintenance packages, technical support, and on-site service visits for Microfluidizer processors.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

Microfluidics designs and manufactures high-shear Microfluidizer® processors and homogenizers used for nanoemulsions, cell disruption, lipid nanoparticle synthesis, liposome production, and particle size reduction. The portfolio spans lab-scale benchtop units, pilot-scale systems, and production-scale processors with cGMP-compliant configurations for pharmaceutical manufacturing. The company also provides proprietary replacement Interaction Chambers, application lab testing services, and aftermarket equipment maintenance.

Product overview

Microfluidics Corporation offers a comprehensive portfolio of Microfluidizer high shear fluid processors and related technologies for nano-scale particle processing. The product line spans from lab scale (LM10, LM20, M110P, LV1, M110Y, HC Series, TAMARA) through pilot scale (M110EH, M815) to production scale (M700 Series, M7250, MP350 Microlyser). The core Microfluidizer technology provides high-pressure homogenization through proprietary fixed-geometry Interaction Chambers for uniform particle size reduction, cell disruption, and nanoemulsion creation. The 2024-introduced Microlyser technology represents a production-scale solution specifically designed for cell disruption applications. Products serve industries including biopharmaceutical, cosmetics, nutraceuticals, vaccines, energy, and chemicals, with cGMP-accredited models available for pharmaceutical manufacturing.

Differentiator

Problem solved

Functional benefit

Brands

• Microlyser™: Production-scale cell disruption processor utilizing hybrid technology with proprietary Interaction Chamber™ and electric pumping system.
• Microfluidizer®
• Interaction Chamber™

Products and services

• LM10 Microfluidizer A digitally controlled lab-scale benchtop Microfluidizer processor designed for budget-conscious researchers working with small sample material processing.
• LM20 Microfluidizer A digitally controlled, electrically powered lab-scale benchtop Microfluidizer processor for small sample processing.
• M110P Microfluidizer A premium 'plug and play' benchtop homogenizer for continuous high shear fluid processing in the lab.
• LV1 Low Volume Microfluidizer A lab-scale Microfluidizer unit for small sample material processing down to the milliliter scale, ideal for academic and commercial customers working with high-value samples.
• M110Y Microfluidizer A portable, high-pressure pneumatic, high shear fluid lab homogenizer for micro-mixing applications in the lab.
• HC Series Microfluidizers (HC 5000/8000) Versatile sanitary standard air-driven homogenizers offering repeatable, premium results at an affordable price for lab-scale processing.
• TAMARA Nanoparticle Formulation System A microfluidic-based platform for precise synthesis of polymer and lipid-based nanoparticles including LNPs, liposomes, and PLGAs, with controlled particle size, polydispersity index (PDI), and encapsulation efficiency (EE%).
• M110EH Microfluidizer An electric-hydraulic pilot scale homogenizer for continuous, high shear fluid processing in small volumes with results guaranteed to fully scale up to production volumes.
• M110EH Basic Biopharma Microfluidizer An electric-hydraulic pilot-scale Microfluidizer designed to achieve cGMP standards when processing small sample sizes for biopharmaceutical applications.
• M110EH Pharma Aseptic Microfluidizer A pilot-scale Microfluidizer designed to achieve cGMP standards with aseptic capability, ideal for pilot-scale batch processing in biopharmaceutical manufacturing.
• M815 Microfluidizer A pilot-scale homogenizer bridging lab and production, ideal for high shear fluid processing with small sample sizes.
• M815 Pharma Basic Microfluidizer A pilot-scale Microfluidizer designed to achieve cGMP standards, processing pilot and small production batches while allowing users to replicate operating conditions.
• M700 Series Microfluidizers Production-scale Microfluidizer processors delivering the finest and most uniform distribution of submicron particle size at the highest shear rates available.
• M7250 Pharma Aseptic Microfluidizer A production-scale Microfluidizer specifically designed to achieve cGMP standards with superior results for production environments and guaranteed scale-up from lab and pilot scale volumes.
• MP350 Microlyser™ Processor A production-scale processor utilizing a hybrid approach with proprietary Interaction Chamber technology and a unique sanitary electric pumping system, delivering superior cell disruption yields.
• M110P Pharma Basic Microfluidizer A lab-scale Microfluidizer designed to reliably achieve continuous operating pressures up to 30,000 psi for clinical batch processing in biopharmaceutical applications.
• Interaction Chambers Proprietary fixed-geometry Interaction Chambers designed to provide repeatable results and consistent quality in Microfluidizer processors, no matter the processing volume.
• Application Lab Testing Services Engineers provide application testing and development services using Microfluidizer technology to help customers achieve nanotechnology solutions and evaluate equipment for their specific use cases.
• Aftermarket Equipment Maintenance and Support Comprehensive aftermarket services including maintenance packages, technical support, and on-site service visits for Microfluidizer processors.

Quantifiable outcome

• 55% smaller emulsions compared to valve homogenizers at same energy input for vaccine adjuvant production
• +4 more outcomes

Named customers8 records

Segments6 records

Ideal customer profiles6 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• HDT BiocoreStrategic or Co-development PartnerHDT Bio uses Microfluidizer® processors as part of their proprietary drug delivery technology for next-generation RNA vaccines and therapeutics. Dr. Darrick Carter of HDT Bio has presented on the scalable production solution for RNA-LNP delivery systems.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Constant Systems: Constant Systems specializes in high-pressure cell disruption equipment for biotech, pharma, and academic research. They are a direct competitor in the cell disruption niche where Microfluidics' Microlyser and M-series processors operate, with comparable pressure ratings and scalability claims.
• Avestin (Emulsiflex): Avestin manufactures Emulsiflex high-pressure homogenizers that are the closest direct competitor to Microfluidizer processors in lab, pilot, and production scale cell disruption and nanoemulsion applications. Both companies target pharma/biotech and academic customers with similar benchtop-to-production product lines.
• SPX Flow (APV Homogenizers): SPX Flow's APV homogenizer line is a longstanding competitor in high-pressure homogenization for pharma, food, and chemical applications. Their products overlap with Microfluidizer processors at pilot and production scale, with comparable cGMP offerings for biopharma.
• GEA Niro Soavi: GEA Niro Soavi is a leading manufacturer of high-pressure homogenizers used in pharma, biotech, dairy, and food applications. They compete head-to-head with Microfluidics in nanoemulsion, liposome, and cell disruption applications at lab through production scale.
• PhD Technology (Microfluidizer clone): PhD Technology (formerly Microfluidics' original R&D spin-out from Arthur D. Little) manufactures clone microfluidizer-style high-pressure homogenizers using similar fixed-geometry interaction chambers. They are a direct competitor in lab and production-scale particle size reduction across pharma and biotech.
• BEE International: BEE International manufactures high-pressure homogenizers used in pharmaceutical, biotech, cosmetics, and food applications for nanoemulsion and particle size reduction. Their technology platform overlaps with Microfluidizer processors at lab and production scale, with similar customer use cases.

Broad incumbents

• GEA Group: GEA is a large-scale process equipment manufacturer covering separation, homogenization, and aseptic processing across pharma, food, and dairy. Through its Niro Soavi and pharmaceutical separations divisions, GEA competes broadly with Microfluidics in biological and pharmaceutical processing equipment.

Emerging players

• Hielscher Ultrasonics: Hielscher manufactures industrial ultrasonic processors used for cell disruption, nanoparticle synthesis, and nanoemulsion production in pharma, biotech, cosmetics, and food. They compete with Microfluidizer processors at smaller scale and in continuous-flow ultrasonic applications.
• Sonics & Materials (Vibracell): Sonics & Materials makes ultrasonicators (Vibracell) used as an alternative technology for cell disruption and nanoparticle formation in biotech and academic labs. While not identical to high-pressure homogenization, they compete in overlapping use cases for cell lysis and nanoparticle production at the research scale.
• Precision Nanosystems (Cytiva): Precision Nanosystems, now part of Cytiva/Danaher, makes the NanoAssemblr microfluidic platform for LNP, liposome, and nanoparticle formulation. They are a key emerging competitor in the RNA-LNP manufacturing space where Microfluidics is also active, although they focus more on the formulation step than scale-up to production volumes.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/channel/UCXWgOO1jWKIykC2vDCx5EVA
• LinkedInlinkedin.com/company/microfluidics

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Microfluidic Tech Corp.